Eph receptors as therapeutic targets in glioblastoma

per Day, B W, Stringer, B W, Boyd, A W
Publicat 2014

Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways

per Hallal, S., Mallawaaratchy, D. M., Wei, H., Ebrahimkhani, S., Stringer, B. W., Day, B. W., Boyd, A. W., Guillemin, G. J., Buckland, M. E., Kaufman, Kimberley L.
Publicat a Mol Neurobiol (2018)

P01.07 The Dystroglycan Complex Promotes Mesenchymal-Like Glioblastoma through Interaction with EphA Receptor Tyrosine Kinases

per Day, B. W., Al-Ejeh, F., Bruce, Z. C., Ensbey, K. S., Robertson, T., Stringer, B. W., Rich, J. N., Lathia, J. D., Campbell, K. P., Boyd, A. W.
Publicat a Neuro Oncol (2017)

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

per Greenall, S A, Lim, Y C, Mitchell, C B, Ensbey, K S, Stringer, B W, Wilding, A L, O'Neill, G M, McDonald, K L, Gough, D J, Day, B W, Johns, T G
Publicat a Oncogenesis (2017)

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

per Zakaria, Z, Tivnan, A, Flanagan, L, Murray, D W, Salvucci, M, Stringer, B W, Day, B W, Boyd, A W, Kögel, D, Rehm, M, O'Brien, D F, Byrne, A T, Prehn, J H M
Publicat a Br J Cancer (2016)